Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amir Kavianpour"'
Autor:
Paul L. Wood, Dayan B. Goodenowe, Shawn Ritchie, Yingshen Lu, Wei Jin, Elodie Pastural, Amir Kavianpour, Khine Khine Su-Myat, Doug Heath, Maura Fisk
Publikováno v:
Prostaglandins, Leukotrienes and Essential Fatty Acids. 81:253-264
Autism is a neurological disorder that manifests as noticeable behavioral and developmental abnormalities predominantly in males between the ages of 2 and 10. Although the genetics, biochemistry and neuropathology of this disease have been extensivel
Publikováno v:
Canadian Journal of Chemistry. 86:368-375
Herein, we report the synthesis, characterization, and post-functionalization of Au nanoparticles that have been surface-modified with glycine–cystamine (Gly-CSA) stabilizing groups. We show that Au monolayer protected clusters (MPCs) can be synthe
Autor:
Amir Kavianpour, Kazuyuki Matsushita, Yasuyo Yamazaki, Fumio Nomura, Masakazu Miyake, Ichiro Takemasa, Kazuyuki Sogawa, Doug Heath, Kevin Krenitsky, Morito Monden, Hoda Elshoni, Shawn Ritchie, Hisahiro Matsubara, Bryan Grimmalt, Dayan B. Goodenowe, Takeshi Tomonaga, Mitsugu Sekimoto
Publikováno v:
BMC Gastroenterology, Vol 10, Iss 1, p 140 (2010)
BMC Gastroenterology
BMC Gastroenterology
Background Serum levels of novel hydroxy polyunsaturated ultra long-chain fatty acids (hPULCFAs) have been previously shown to be reduced in pre-treatment CRC patients compared to disease-free subjects, independent of disease stage. However, whether
Autor:
Mitsugu Sekimoto, Morito Monden, Wei Jin, Dayan B. Goodenowe, Amin Khan, Paul L. Wood, Khine Khine Su-Myat, Mohammad Shawkat Hossain, Shawn Ritchie, Hisahiro Matsubara, Amir Kavianpour, Jun-Jun Liu, Ichiro Takemasa, Yingshen Lu, Doug Heath, Fumio Nomura, Kevin Krenitsky, Dushmanthi Jayasinghe, Masakazu Miyake, Yasuyo Yamazaki, Pearson W.K. Ahiahonu
Publikováno v:
BMC Medicine, Vol 8, Iss 1, p 13 (2010)
BMC Medicine
BMC Medicine
Background There are currently no accurate serum markers for detecting early risk of colorectal cancer (CRC). We therefore developed a non-targeted metabolomics technology to analyse the serum of pre-treatment CRC patients in order to discover putati